Tim Van-Assche

492 total citations
6 papers, 381 citations indexed

About

Tim Van-Assche is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Tim Van-Assche has authored 6 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Surgery, 3 papers in Cardiology and Cardiovascular Medicine and 2 papers in Molecular Biology. Recurrent topics in Tim Van-Assche's work include CRISPR and Genetic Engineering (2 papers), Coronary Interventions and Diagnostics (2 papers) and Pregnancy and preeclampsia studies (1 paper). Tim Van-Assche is often cited by papers focused on CRISPR and Genetic Engineering (2 papers), Coronary Interventions and Diagnostics (2 papers) and Pregnancy and preeclampsia studies (1 paper). Tim Van-Assche collaborates with scholars based in United Kingdom, Greece and Norway. Tim Van-Assche's co-authors include Charalambos Antoniades, Keith M. Channon, Paul Leeson, Dimitris Tousoulis, Christodoulos Stefanadis, Colin Cunnington, Cheerag Shirodaria, Ravi Pillai, C Ratnatunga and Alexios S. Antonopoulos and has published in prestigious journals such as Circulation, European Heart Journal and Current Pharmaceutical Design.

In The Last Decade

Tim Van-Assche

6 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tim Van-Assche United Kingdom	4	141	112	88	70	46	6	381
Serena Masetti Italy	8	110 0.8×	108 1.0×	140 1.6×	221 3.2×	19 0.4×	8	533
Deborah M. Lenda United States	6	132 0.9×	185 1.7×	132 1.5×	66 0.9×	38 0.8×	6	599
Sharad Agarwal United Kingdom	7	206 1.5×	235 2.1×	23 0.3×	74 1.1×	36 0.8×	10	508
Allison B. Lehtinen United States	13	55 0.4×	126 1.1×	36 0.4×	158 2.3×	58 1.3×	16	508
Yukiko Kanetsuna Japan	9	93 0.7×	49 0.4×	79 0.9×	165 2.4×	30 0.7×	28	550
L Kazdová Czechia	9	111 0.8×	51 0.5×	46 0.5×	158 2.3×	23 0.5×	18	353
Anne-Roos S. Frenay Netherlands	12	100 0.7×	99 0.9×	30 0.3×	125 1.8×	173 3.8×	22	538
Ruc Tran United States	8	139 1.0×	90 0.8×	38 0.4×	163 2.3×	20 0.4×	13	531
Maike Anderssohn Germany	9	185 1.3×	186 1.7×	18 0.2×	67 1.0×	46 1.0×	10	387
Ceyda Kabaroğlu Türkiye	12	79 0.6×	48 0.4×	48 0.5×	117 1.7×	21 0.5×	26	439

Countries citing papers authored by Tim Van-Assche

Since Specialization

Citations

This map shows the geographic impact of Tim Van-Assche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Van-Assche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Van-Assche more than expected).

Fields of papers citing papers by Tim Van-Assche

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim Van-Assche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Van-Assche. The network helps show where Tim Van-Assche may publish in the future.

Co-authorship network of co-authors of Tim Van-Assche

This figure shows the co-authorship network connecting the top 25 collaborators of Tim Van-Assche. A scholar is included among the top collaborators of Tim Van-Assche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tim Van-Assche. Tim Van-Assche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Van-Assche, Tim, V. Huygelen, Mark J. Crabtree, & Charalambos Antoniades. (2013). Gene Delivery Strategies Targeting Stable Atheromatous Plaque. Current Pharmaceutical Design. 19(9). 1626–1637. 2 indexed citations

2.

Van-Assche, Tim, V. Huygelen, Mark J. Crabtree, & Charalambos Antoniades. (2013). Gene Delivery Strategies Targeting Stable Atheromatous Plaque. Current Pharmaceutical Design. 19(9). 1626–1637. 3 indexed citations

3.

Van-Assche, Tim, V. Huygelen, Mark J. Crabtree, & Charalambos Antoniades. (2011). Gene Therapy Targeting Inflammation in Atherosclerosis. Current Pharmaceutical Design. 17(37). 4210–4223. 32 indexed citations

4.

Antoniades, Charalambos, Cheerag Shirodaria, Paul Leeson, et al.. (2009). Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis. European Heart Journal. 30(9). 1142–1150. 191 indexed citations

5.

Antoniades, Charalambos, Cheerag Shirodaria, Paul Leeson, et al.. (2009). MTHFR 677 C>T Polymorphism Reveals Functional Importance for 5-Methyltetrahydrofolate, Not Homocysteine, in Regulation of Vascular Redox State and Endothelial Function in Human Atherosclerosis. Circulation. 119(18). 2507–2515. 122 indexed citations

6.

Antoniades, Charalambos, Tim Van-Assche, Cheerag Shirodaria, et al.. (2009). Preoperative sCD40L Levels Predict Risk of Atrial Fibrillation After Off-Pump Coronary Artery Bypass Graft Surgery. Circulation. 120(11_suppl_1). S170–6. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact